Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
Completed
Merck Sharp & Dohme Corp.
Phase 4
2007-10-01
The purpose of this study is to compare the effects of two marked ocular anti-allergy
medications in cat sensitive subjects with allergic conjunctivitis.
Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis
Completed
University of Worcester
Phase 4
2012-03-01
Seasonal allergic conjunctivitis (SAC) is an irritating eye condition that affects many
people, caused by hypersensitivity to normally harmless substances such as pollen, and often
accompanies seasonal hay fever. Treatments that can be used before initiating medical therapy
include artificial tear supplements (ATS) and cold compresses (CC). However, there is no
evidence in the scientific literature that demonstrates their efficacy compared to no
treatment or their combined effect with anti-allergic medication. Therefore the investigators
aim to examine the efficacy of ATS and CC alone, in comparison to anti-allergic medication,
and CC in combination with anti-allergic medication. In addition, the investigators also aim
to determine the time course of ocular allergic reactions. At the end of the study the
investigators will be able to see whether or not ATS and CC are effective in treating SAC.
Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis
Completed
Aston University
Phase 4
2012-03-01
Seasonal allergic conjunctivitis (SAC) is an irritating eye condition that affects many
people, caused by hypersensitivity to normally harmless substances such as pollen, and often
accompanies seasonal hay fever. Treatments that can be used before initiating medical therapy
include artificial tear supplements (ATS) and cold compresses (CC). However, there is no
evidence in the scientific literature that demonstrates their efficacy compared to no
treatment or their combined effect with anti-allergic medication. Therefore the investigators
aim to examine the efficacy of ATS and CC alone, in comparison to anti-allergic medication,
and CC in combination with anti-allergic medication. In addition, the investigators also aim
to determine the time course of ocular allergic reactions. At the end of the study the
investigators will be able to see whether or not ATS and CC are effective in treating SAC.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
